Product
Therapeutic Autologous Lymphocytes
1 clinical trial
1 indication
Indication
Brain NeoplasmsClinical trial
Anti-Tumor Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed Glioblastoma Multiforme During Recovery From Therapeutic Temozolomide-induced LymphopeniaStatus: Completed, Estimated PCD: 2017-04-15